US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 1, 2019 (8 years ago)

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Container: Potential for broken glass in the neck area of the glass bottles.

What was recalled

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.

Recalling firm
Mylan Pharmaceuticals Inc.
NDC code
0037-0245-23
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0424-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all